ReviewGenes2019
PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development.
Verneri Virtanen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled itcites it
ReviewGenes2019
Verneri Virtanen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.